Qu Biologics' Grant

Qu Biologics raised a round of funding on April 06, 2016. Investors include Genome British Columbia.

Qu Biologics develops Site Specific Immunomodulators (SSI), a novel class of immunotherapies that aim to restore the body's normal immune response. SSIs are designed to stimulate an immune response in…

Articles about Qu Biologics' Grant: